[A medical economic benefit of outpatient with cancer chemotherapy].
Recently, there is a worldwide tendency to decrease medical costs, and a medical insurance revolution, such as a diagnosis procedure combination system, has also been put forward in Japan. It is important to consider medical management healthily by shortening hospital stays and cutting the cost of admission therapies. In this background, outpatients' chemotherapy takes notice because of the improvement in quality of life, discovery of new drugs without severe adverse effects, use-effectiveness of hospital beds and medical cost-effectiveness. Cancer patients suffer from not only a major burden of the diseases such as their physical and mental state, but also an economic impact. In this article, we review the medical cost-benefit for outpatients undergoing cancer chemotherapy.
Uramoto
Hidetaka
H
Cancer Chemotherapy Center, University Hospital, University of Occupational and Environmental Health, Japan. Yahatanishi-ku, Kitakyushu 807-8555, Japan.
Iwashige
Atsushi
A
Kagami
Seiji
S
Tsukada
Junichi
J
D000553:Ambulatory Care / Q000191:economics*; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D007902:Length of Stay / Q000191:economics; D009369:Neoplasms / Q000188:drug therapy*; D010045:Outpatients; D011788:Quality of Life
D000970:Antineoplastic Agents